Stock Track | Ardelyx Plunges 7.12% After-Hours on Earnings Miss and Widening Losses

Stock Track
15 hours ago

Ardelyx Inc. (ARDX) shares plummeted 7.12% in after-hours trading on Thursday following the release of its fourth quarter and full-year 2025 financial results.

The biopharmaceutical company reported quarterly earnings of $0.00 per share, which missed the analyst consensus estimate of $0.01 by 85.71%. This represents a 95% decrease compared to earnings of $0.02 per share from the same period last year. While quarterly sales of $125.215 million beat estimates, the significant earnings disappointment and a widening full-year net loss appear to have driven investor selling pressure.

According to the financial reports, Ardelyx's net loss for 2025 widened to $61.6 million from $39.1 million in 2024, indicating continued challenges in achieving profitability despite revenue growth from its key products.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10